Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Interested in the college golf coaching scene around the country in 2026? Get the latest updates on this page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results